Cuprina Holdings (Cayman) Ltd (CUPR) USD0.001
Sell:$4.40Buy:$4.77
$0.08
(1.79%)
- This stock can be held in a
Stocks and Shares ISA$0.08
(1.79%)$0.08
(1.79%)Company Information
About this company
Cuprina Holdings (Cayman) Limited is a biomedical and biotechnology company. The Company is dedicated to the development and commercialization of products for the management of chronic wounds, as well as operating in the health and beauty sectors. The Company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as Maggot Debridement Therapy (MDT), which is an alternative to surgical debridement. It also offers two lines of chronic wound care products in its pipeline. Such lines of pipeline chronic wound care products include Collagen dressings, including sponges, particles and hydrogels utilizing bullfrog collagen derived from the valorization of abattoir waste streams of American bullfrogs (Lithobates catesbeianus), and Products utilizing medical leeches for wound treatment.
Key people
Key facts
- EPICCUPR
- LocationSingapore
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINKYG2592E1026
- Market cap$96.10m
- Employees14
- Shares in issue7.37m
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.